Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study.
Nicoletto MO, Tumolo S, Talamini R, Salvagno L, Franceschi S, Visonà E, Marin G, Angelini F, Brigato G, Scarabelli C, Carbone A, Cecchetto A, Prosperi A, Rosabian A, Giusto M, Cima GP, Morassut S, Nascimben O, Vinante O, Fiorentino MV. Nicoletto MO, et al. Among authors: angelini f. J Clin Oncol. 1997 Mar;15(3):994-9. doi: 10.1200/JCO.1997.15.3.994. J Clin Oncol. 1997. PMID: 9060538 Clinical Trial.
The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V, Cocconi G, Angelini F, Cavicchi F, Di Costanzo F, Gilli G, Rodinò C, Soldani M, Tonato M, Finardi C. De Lisi V, et al. Among authors: angelini f. Cancer. 1996 Jan 15;77(2):245-50. doi: 10.1002/(SICI)1097-0142(19960115)77:2<245::AID-CNCR4>3.0.CO;2-L. Cancer. 1996. PMID: 8625230 Clinical Trial.
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.
Gamucci T, Mentuccia L, Natoli C, Sperduti I, Cassano A, Michelotti A, Di Lauro L, Sergi D, Fabi A, Sarobba MG, Marchetti P, Barba M, Magnolfi E, Maugeri-Saccà M, Rossi E, Sini V, Grassadonia A, Pellegrini D, Astone A, Nisticò C, Angelini F, Vaccaro A, Pellegrino A, De Angelis C, Palleschi M, Moscetti L, Bertolini I, Buglioni S, Giordano A, Pizzuti L, Vici P. Gamucci T, et al. Among authors: angelini f. J Cell Physiol. 2017 Jun;232(6):1571-1578. doi: 10.1002/jcp.25685. Epub 2016 Nov 30. J Cell Physiol. 2017. PMID: 27861874 Free PMC article.
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis.
Gridelli C, Ianniello G, Ambrosini G, Mustacchi G, Pedicini T, Farris A, Iacobelli S, Rossi G, Moretti G, Angelini F, Delena M, Dicarlo A, Bonsignori M, Sabbatini R, Catalano G, Rossi A, Olivieri A, Fina P, Bianco A. Gridelli C, et al. Among authors: angelini f. Int J Oncol. 1997 Feb;10(2):395-400. doi: 10.3892/ijo.10.2.395. Int J Oncol. 1997. PMID: 21533390
What hides beneath the scar: sexuality and breast cancer what women don't say: A single-center study.
Gozzi E, La Manna AR, Rossi L, Colonna M, Ulgiati MA, Romagnoli L, Busco S, Parrocchia S, Marrone R, Iavarone C, Arcangeli G, Angelini F, De Masi C, Ambrogi C, Travaini S, Calogero A, Centra A, Ricci F. Gozzi E, et al. Among authors: angelini f. Clin Ter. 2022 Jul-Aug;173(4):342-346. doi: 10.7417/CT.2022.2443. Clin Ter. 2022. PMID: 35857051 Free article.
422 results